Fabiola Pérez-González

85 - OPTIMIZACIÓN FARMACOCINÉTICA PROACTIVA DEL TRATAMIENTO DE MANTENIMIENTO CON USTEKINUMAB EN PACIENTES CON ENFERMEDAD INFLAMATORIA INTESTINAL

Fabiola Pérez-González, Rashika Ashok Bhagchandani, Cristina Reygosa, Marta Carrillo-Palau et autres

An Artificial Intelligence-Guided Strategy to Reduce Poor Bowel Preparation: A Multicenter Randomized Controlled Study

Antonio Zebenzui Gimeno-García, Federica Benítez-Zafra, Ignacio Redondo-Zaera, Noelia Cruz-Perdomo et autres

INTRODUCTION: Proper bowel preparation is crucial for increasing the adenoma detection rate. A novel application based on the use of a convolutional neural network can differentiate between adequate and inadequate bowel preparation on the basis of images of rectal effluents taken before …

es (code pays fourni par la source)

DOP103 Optimization of Ustekinumab Treatment Induction Using a Pharmacokinetic Model in Inflammatory Bowel Disease Patients

Laura Ramos López, Betel Del Rosario-García, Fabiola Pérez-González, Inmaculada Alonso-Abreu et autres

Abstract Background Therapeutic drug monitoring and pharmacokinetic modeling, implemented in the treatment of patients with inflammatory bowel disease (IBD), improve drug efficacy and reduce side effects. Recently, Ustekinumab (UST) levels associated with therapeutic targets have been established, principally during induction, highlighting the …

es (code pays fourni par la source)

COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

Laura Ramos, Marta Carrillo‐Palau, Inmaculada Alonso-Abreu, Cristina Reygosa et autres

es (code pays fourni par la source)

22 - UTILIDAD Y OPTIMIZACIÓN DEL USO DE LA CÁPSULA ENDOSCÓPICA DE INTESTINO DELGADO EN PACIENTES AMBULATORIOS

Fabiola Pérez-González, Belén Vera-Santana, Onofre Alarcón, Antonio Z. Gimeno‐García et autres

COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire

Laura Ramos, Marta Carrillo‐Palau, Inmaculada Alonso-Abreu, Cristina Reygosa et autres

es (code pays fourni par la source)

P694 COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy

L. Ramos López, Marta Carrillo‐Palau, Inmaculada Alonso-Abreu, Cristina Reygosa et autres

Abstract Background Vaccination against COVID19 prevents its severe forms and associated mortality and offers a promising action to control this pandemic. In Spain, by October 2021, 87.9% of the target population, including IBD patients had received the complete vaccination regimen. In September …

es (code pays fourni par la source)

Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients.

Cartón Ja, Maradona Ja, Nuño Mateo Fj, Rubén Fernández-Álvarez et autres

OBJECTIVES: To compare the incidence, mortality, clinical characteristics and outcome between bacteraemias in diabetic and non-diabetic patients. METHODS: A prospective study of all adult patients with bacteraemia admitted to a large Spanish teaching hospital during six consecutive years (1984-1990); 152 were diabetics …

es (code pays fourni par la source)